Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2015-07-07 | Amended | $543,857 | $228,915 | Equity Only | 06b | SEC link |
| 2014-06-13 | New | $314,942 | $314,942 | Equity Only | 06b | SEC link |
| 2013-11-13 | New | $231,069 | $231,069 | Equity Only | 06b | SEC link |
| 2013-07-03 | New | $300,000 | $300,000 | Equity Only | 06 | SEC link |
| 2012-06-07 | New | $298,264 | $298,264 | Debt Only | 06 | SEC link |
| 2011-06-21 | New | $1,217,417 | $1,217,417 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Jesse Baumgold, Ph D | Director, Executive |
| Christopher D. Geddes | Executive |
| William M. Gust, Ii | Director, Executive |
| Sean Higgins, Ph D | Executive |
| John W. Holaday | Director, Executive |
| David Manyak | Director |
| Steven Meltzer | Director |
| Edward M. Rudnic, Ph D | Director |
| James E. Russo | Executive |